Pressure BioSciences Low on Cash as Its Q1 Revenues Fall 38 Percent

The company said that current cash levels will allow the company to fund existing operations to the end of the second quarter of the year.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.